Yokohama, Japan

Sinichi Kondo

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sinichi Kondo: Innovator in Cephem Compounds

Introduction

Sinichi Kondo is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephem compounds. His work has implications for antibacterial treatments, showcasing his innovative spirit and dedication to improving healthcare.

Latest Patents

Kondo holds a patent for new cephem compounds, specifically designed to exhibit strong antibacterial activities. These compounds are represented by a general formula that includes various functional groups, demonstrating their potential effectiveness against resistant strains of bacteria, gram-negative bacteria, and gram-positive bacteria. Notably, these cephem compounds have very low toxicity, making them a promising option for medical applications.

Career Highlights

Throughout his career, Sinichi Kondo has been associated with Meiji Seika Kaisha, Ltd., where he has focused on research and development in the pharmaceutical sector. His innovative work has led to advancements in antibiotic treatments, contributing to the fight against bacterial infections.

Collaborations

Kondo has collaborated with esteemed colleagues such as Yuichi Yamamoto and Kunio Atsumi. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Sinichi Kondo's contributions to the field of cephem compounds highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in antibacterial treatments, showcasing the importance of research and collaboration in the pursuit of medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…